Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males

Journal of Neural Transmission

Volumn 110, Issue 4, 2003, Pages 345-351

  Hong, C J ^a,b   Cheng, C Y ^a   Shu, L R R ^a   Yang, C Y ^a   Tsai, S J ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Association study; Dopamine transporter; Male; Methamphetamine dependence; Polymorphism; Serotonin transporter

Indexed keywords

DOPAMINE TRANSPORTER; METHAMPHETAMINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; MINISATELLITE REPEATS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE-RELATED DISORDERS;

EID: 0037387291     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0790-8     Document Type: Article

References (29)

1. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53: 649-655
2. Chen JW, Chang YY, Shieh V (1995) An investigation of junior high students' attitudes toward amphetamine use and related forms of behavior. Kao-Hsiung I Hsueh Ko Hsueh Tsa Chih 11: 557-563
3. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278
4. Edenberg HJ, Reynolds J, Koller DL, Begleiter H, Bucholz KK, Conneally PM, Crowe R, Goate A, Hesselbrock V, Li TK, Nurnberger JI Jr, Porjesz B, Reich T, Rice JP, Schuckit M, Tischfield JA, Foroud T (1998) A family-based analysis of whether the functional promoter alleles of the serotonin transporter gene HTT affect the risk for alcohol dependence. Alcohol Clin Exp Res 22: 1080-1085
5. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994) Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11: 195-200
6. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612
7. Gorwood P, Batel P, Ades J, Hamon M, Boni C (2000) Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 48: 259-264
8. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66: 2621-2624
9. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22: 133-139
10. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157: 1700-1703
11. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979-1986
12. Kang AM, Palmatier MA, Kidd KK (1999) Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46: 151-160
13. Lesch KP, Wolozin BL, Murphy DL, Reiderer P (1993) Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 60: 2319-2322
14. Lichtermann D, Hranilovic D, Trixler M, Franke P, Jernej B, Delmo CD, Knapp M, Schwab SG, Maier W, Wildenauer DB (2000) Support for allelic association of a polymorphic site in the promoter region of the serotonin transporter gene with risk for alcohol dependence. Am J Psychiatry 157: 2045-2047
15. MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 96: 15251-15255
16. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA (1996) Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347: 731-733
17. Owen MJ, Holmans P, McGuffin P (1997) Association studies in psychiatric genetics. Mol Psychiatry 2: 270-273
18. Parsian A, Zhang ZH (1997) Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am J Med Genet 74: 480-482
19. Patkar AA, Berrettini WH, Wender B, Sterling R, Gottheil E, Weinstein S (1999) Polymorphisms in the serotonin transporter gene and cocaine dependence. American Psychiatric Association Annual Meeting, Washington DC, May 15-20
20. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR (1993) Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry 34: 265-267
21. Rudnick G, Clark J (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144: 249-263
22. Sato M, Numachi Y, Hamamura T (1992) Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18: 115-122
23. Shaw KP, Chung JH (1997) Methamphetamine and opiate-related fatalities in Taiwan Forensic Medicine Center in 1996. Narc Bull (Taiwan) 2: 1-14
24. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine. Proc Natl Acad Sci USA 98: 5300-5305
25. Tsai SJ, Cheng CY, Shu LRR, Yang CY, Pan CW, Liou YJ, Hong CJ (2002) No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. Psychiatr Genet 12: 29-33
26. Uhl GR (1999) Molecular genetics of substance abuse vulnerability: a current approach. Neuropsychopharmacology 20: 3-9
27. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106
28. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386: 827-830
29. Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187: 547-549